Pramiracetam is an analogue of piracetam, chemical name: N-(2-(bis(isopropylamino)ethyl)-2-oxo-1-pyrrolidine acetamide, is a new pyrrolidone-based brain function improver, indicated for the treatment of memory and recognition impairment, language impairment . Treatment and prevention of Alzheimer’s disease (Alzheimer’s disease).
Pramiracetam, a pyrrolidone-based brain metabolism improver, is a central nervous system drug that improves memory and anti-amnesia, developed by Parke-Davis Pharmaceuticals, Inc. in the U.S. It has a strong ability to improve brain function, enhance memory and promote brain acuity.
Clinical trials have demonstrated that pramiracetam is 6-13 times more active than piracetam (brain rejuvenation), 3-4 times more active than olacetam, and 1.25 times more active than anisiracetam, with low toxicity and good tolerability for long-term use to improve symptoms and delay Alzheimer’s type dementia.